CI
IDXX icon

Corient IA’s Idexx Laboratories IDXX Stock Holding History

Corient IA’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Hold
745
– – 0.36% 84
2026
Q1 		$419K Sell
745
-80
-10% -$51.3K 0.39% 87
2025
Q4 		$558K Hold
825
– – 0.53% 55
2025
Q3 		$527K Sell
825
-51
-6% -$31K 0.39% 86
2025
Q2 		$470K Hold
876
– – 0.28% 133
2025
Q1 		$368K Buy
+876
New +$380K 0.26% 161

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Corient IA's IDXX Position: Q2 2026 in Review

Corient IA held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 745 shares worth $392K. The position accounts for 0.36% of the portfolio, ranked #84.

Corient IA first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $558K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Corient IA held 745 shares of Idexx Laboratories worth $392K as of Q2 2026.
  • Corient IA left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.36% of Corient IA's portfolio in Q2 2026, its #84 holding.
  • Corient IA first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • Corient IA's Idexx Laboratories position peaked at $558K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Corient IA's 13F filing for Q2 2026, filed 12 Aug 2026.